See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
0
0
$0.00
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jun 02, 2026 SMITH SCOTT THOMAS |
SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
|
Buy |
100 | $219.00 | 100 $219.00 $21,900 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $223.76 | 200 $223.76 $44,752 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $222.30 | 200 $222.30 $44,460 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
100 | $223.50 | 100 $223.50 $22,350 |
May 29, 2026 SMITH SCOTT THOMAS |
SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
|
Buy |
250 | $223.32 | 250 $223.32 $55,830 |
May 26, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $236.24 | 200 $236.24 $47,247 |
May 26, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $239.37 | 200 $239.37 $47,874 |
May 11, 2026 JENSEN FLEMMING STEEN |
JENSEN FLEMMING STEEN
See Remarks
|
Sell |
19,460 | $238.49 | 19,460 $238.49 $4,641,021 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
No Historical Insider Transactions found for Ascendis Pharma A/S
TOP